Curocell Inc. (KOSDAQ:372320)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,400
+500 (1.19%)
At close: Sep 18, 2025

Curocell Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Jun '25 Dec '24 Dec '23
Cash & Equivalents
9,1674,5819,917
Short-Term Investments
19,4557,20032,000
Cash & Short-Term Investments
28,62111,78141,917
Cash Growth
-31.72%-71.90%-
Other Receivables
52.378.85608.84
Receivables
52.378.85608.84
Prepaid Expenses
788.27746.64109.74
Other Current Assets
3,023511.2151.17
Total Current Assets
32,48513,04742,787
Property, Plant & Equipment
74,38255,45061,242
Long-Term Investments
1,6961,500-
Other Intangible Assets
2,3701,471520.99
Other Long-Term Assets
262.26263.17419.75
Total Assets
111,48672,021104,969
Accrued Expenses
285.86330.32254.7
Short-Term Debt
14,144800800
Current Portion of Long-Term Debt
34,39034,390-
Current Portion of Leases
436.9494.11502.31
Current Income Taxes Payable
-1.18-
Other Current Liabilities
24,3832,7361,713
Total Current Liabilities
73,64038,7513,270
Long-Term Debt
--39,595
Long-Term Leases
1,4501,6162,020
Other Long-Term Liabilities
677.66662.92552.97
Total Liabilities
82,11142,56745,870
Common Stock
7,1627,1006,806
Additional Paid-In Capital
217,196215,016205,660
Retained Earnings
-217,849-199,095-160,463
Comprehensive Income & Other
22,8666,4347,097
Shareholders' Equity
29,37529,45459,100
Total Liabilities & Equity
111,48672,021104,969
Total Debt
50,42137,30042,918
Net Cash (Debt)
-21,800-25,519-1,000
Net Cash Per Share
-1537.13-1826.04-84.54
Filing Date Shares Outstanding
14.3214.213.61
Total Common Shares Outstanding
14.3214.213.61
Working Capital
-41,155-25,70439,516
Book Value Per Share
2050.812074.344341.49
Tangible Book Value
27,00427,98358,579
Tangible Book Value Per Share
1885.321970.754303.22
Land
12,3425,6995,699
Buildings
37,03423,31023,423
Machinery
15,98215,87915,429
Construction In Progress
--13.95
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.